Literature DB >> 17052218

Do polymorphisms in the human 5-HT3 genes contribute to pathological phenotypes?

K Krzywkowski1.   

Abstract

5-HT3 receptors are members of the Cys-loop superfamily of ligand-gated ion channels. In both the central and the peripheral nervous systems, 5-HT3 receptors excite postsynaptic cells and modulate the release of neurotransmitters from presynaptic neurons. 5-HT3 receptors are known to be involved in mediation of nausea/emesis caused by chemo/radio-therapy and anaesthesia, and more recently have also been found to be involved in irritable bowel syndrome. 5-HT3 receptors have also been suggested to play a role in a range of other indications, including various psychiatric disorders. This review summarizes the current evidence for the contribution of 5-HT3 subunit genes to disease phenotypes arising from association studies. Furthermore, it suggests how in vitro characterization of naturally occurring genetic variants can be used to obtain a better understanding of the causal relationship between gene and disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052218     DOI: 10.1042/BST0340872

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  5 in total

1.  Examination of association of genes in the serotonin system to autism.

Authors:  B M Anderson; N C Schnetz-Boutaud; J Bartlett; A M Wotawa; H H Wright; R K Abramson; M L Cuccaro; J R Gilbert; M A Pericak-Vance; J L Haines
Journal:  Neurogenetics       Date:  2009-01-28       Impact factor: 2.660

Review 2.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

Review 3.  3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors.

Authors:  Anders A Jensen; Paul A Davies; Hans Bräuner-Osborne; Karen Krzywkowski
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

Review 4.  Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists?

Authors:  Morgan Trammel; Mary Roederer; Jai Patel; Howard McLeod
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

5.  Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.

Authors:  Min-Soo Kim; Jeong-Rim Lee; Eun-Mi Choi; Eun Ho Kim; Seung Ho Choi
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.